| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 04/07/23 | UPLOAD | SEC-generated letter |
|
1 | |
| 04/03/23 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
35 | |
| 03/22/23 | DEF 14A | Definitive proxy statements |
|
57 | |
| 03/10/23 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
57 | |
| 03/03/23 | 8-K | Current report filing |
|
   |
7 |
| 02/27/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/10/23 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 | |
| 01/23/23 | 8-K | Current report filing |
|
|
3 |
| 01/18/23 | 10-Q/A | Quarterly report pursuant to Section 13 or 15(d) |
|
|
32 |
| 01/17/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
28 |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.